Catalyst Pharmaceuticals Inc. Common Stock is a biopharmaceutical company focused on developing innovative therapies for rare neurological disorders. With a strong pipeline of potential treatments, Catalyst is committed to improving the lives of patients with unmet medical needs.
Notification